摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-bromo-2-chloromethyl-3-nitroimidazo[1,2-a]pyridine

中文名称
——
中文别名
——
英文名称
6-bromo-2-chloromethyl-3-nitroimidazo[1,2-a]pyridine
英文别名
6-Bromo-2-(chloromethyl)-3-nitroimidazo[1,2-a]pyridine
6-bromo-2-chloromethyl-3-nitroimidazo[1,2-a]pyridine化学式
CAS
——
化学式
C8H5BrClN3O2
mdl
——
分子量
290.504
InChiKey
RMHRTCYJCAYXMX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    63.1
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-bromo-2-chloromethyl-3-nitroimidazo[1,2-a]pyridine四(三苯基膦)钯 sodium carbonate 作用下, 以 二甲基亚砜 为溶剂, 反应 6.0h, 生成 2-(4-chlorophenyl)sulfonylmethyl-3-nitro-6-[3-(trifluoromethyl)phenyl]imidazo[1,2-a]pyridine
    参考文献:
    名称:
    Efficient Synthesis of New 8-Aryl Tricyclic Pyridinones
    摘要:
    以 6-溴-2-氯甲基-3-硝基咪唑并[1,2-a]吡啶为原料,通过四个步骤合成了新的三环吡啶酮,其中关键步骤包括铃木-宫浦交叉偶联反应和与酮丙二酸二乙酯的直接烯化反应。随后的一锅还原-环化反应提供了新的 8-芳基-2-氧代-1,2-二氢二吡啶并[1,2-a;3′,2′-d]咪唑-3-羧酸乙酯。
    DOI:
    10.1055/s-2006-942505
  • 作为产物:
    描述:
    6-溴-2-(氯甲基)咪唑并[1,2-a]吡啶硫酸硝酸 作用下, 以100%的产率得到6-bromo-2-chloromethyl-3-nitroimidazo[1,2-a]pyridine
    参考文献:
    名称:
    Targeting the human parasite Leishmania donovani: Discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series
    摘要:
    We report herein the discovery of antileishmanial molecules based on the imidazo[1,2-a]pyridine ring. In vitro screenings of imidazopyridines belonging to our chemical library, toward the promastigotes stage of Leishmania donovani, J774A. 1 murine and HepG2 human cells, permitted to identify three selective hit-compounds (12, 20 and 28). New derivatives were then synthesized to allow structure-activity and -toxicity relationships analyses, enabling to characterize a lead-compound (44) displaying both a high potency (IC50 = 1.8 mu M) and a good selectivity index, in comparison with three antileishmanial reference drug-compounds (amphotericin B, miltefosine and pentamidine). Moreover, lead-compound 44 also exhibits good in vitro activity against the intracellular amastigote stage of L. donovani. Thus, the 6-halo-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridine scaffold appears as a new promising selective antileishmanial pharmacophore, especially when substituted at position 8 by a bromine atom. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2013.09.002
点击查看最新优质反应信息

文献信息

  • Synthesis and Structural Characterization of Three Phenylsulfonyl Derivatives: Influence of Halogen Substituents on the Intermolecular Interactions
    作者:C. Castera、M. D. Crozet、M. Giorgi、P. Vanelle
    DOI:10.1007/s10870-007-9256-z
    日期:2007.11.7
    Synthesis and X-ray structural determination of three halogenated nitroimidazo[1,2-a]pyridine phenylsulfonyl derivatives are reported. (2) is monoclinic P21/c with a = 9.6679(1), b = 11.3642(2), c = 15.2189(2)Å, β = 105.9053(7)°; (3) is triclinic P −1 with a = 8.5556(2), b = 13.1191(3), c = 15.5132(4)Å, α = 76.0110(8), β = 89.1768(8), γ = 78.953(2)°; (4) is monoclinic P21/c with a = 15.3353(2), b = 8.8621(2), c = 11.4189(3)Å, β = 90.9704(7)°. In the title compounds that differ by the nature and number of halogen substituents, the arylsulfonyl moieties are oriented differently relatively to the nitroimidazopyridine. Moreover non-classical intermolecular interactions are revealed by the X-ray analysis. The X-ray structures of three halogenated nitroimidazo[1,2-a]pyridine phenylsulfonyl derivatives reveal different intermolecular interactions within the crystals. C. Castera, M. D. Crozet, M. Giorgi and P. Vanelle The X-ray structures of three halogenated nitroimidazo[1,2-a]pyridine phenylsulfonyl derivatives reveal different intermolecular interactions within the crystals. Synthesis and structural characterization of three phenylsulfonyl derivatives: influence of halogen substituents on the intermolecular interactions. C. Castera,1 M. D. Crozet,1 M. Giorgi,2 and P. Vanelle1* 1Laboratoire de Chimie Organique Pharmaceutique, UMR CNRS 6517, Université de la Méditerranée, Faculté de Pharmacie, 27 Boulevard Jean Moulin, 13385 Marseille cedex 5, France ; 2Spectropôle-RX, Université Paul Cézanne Aix-Marseille III, Faculté des Sciences et Techniques, Avenue Escadrille Normandie-Niemen, 13397 Marseille cedex 20, France.
    报告了三种卤代硝基咪唑并[1,2-a]吡啶苯磺酰衍生物的合成和 X 射线结构测定。(2)为单斜 P21/c,a = 9.6679(1),b = 11.3642(2),c = 15.2189(2)埃,β = 105.9053(7)°;(3)为三菱形 P-1,a = 8.5556(2),b = 13.1191(3),c = 15.5132(4)埃,α = 76.0110(8),β = 89.1768(8),γ = 78.953(2)°;(4)为单斜 P21/c,a = 15.3353(2),b = 8.8621(2),c = 11.4189(3)埃,β = 90.9704(7)°。在卤素取代基的性质和数量不同的标题化合物中,芳基磺酰基相对于硝基咪唑吡啶的取向不同。此外,X 射线分析还揭示了非典型的分子间相互作用。三种卤代硝基咪唑并[1,2-a]吡啶苯磺酰基衍生物的 X 射线结构揭示了晶体内部不同的分子间相互作用。C. Castera、M. D. Crozet、M. Giorgi 和 P. Vanelle 三种卤代硝基咪唑并[1,2-a]吡啶苯磺酰基衍生物的 X 射线结构揭示了晶体内部不同的分子间相互作用。三种苯磺酰基衍生物的合成与结构表征:卤素取代基对分子间相互作用的影响。C. Castera,1 M. D. Crozet,1 M. Giorgi,2 and P. Vanelle1* 1.Vanelle1* 1Laboratoire de Chimie Organique Pharmaceutique, UMR CNRS 6517, Université de la Méditerranée, Faculté de Pharmacie, 27 Boulevard Jean Moulin, 13385 Marseille cedex 5, France; 2Spectropôle-RX, Université Paul Cézanne Aix-Marseille III, Faculté des Sciences et Techniques, Avenue Escadrille Normandie-Niemen, 13397 Marseille cedex 20, France.
  • An Efficient Synthetic Route to New Imidazo[1,2-a]pyridines by Cross-Coupling Reactions in Aqueous Medium
    作者:Patrice Vanelle、Caroline Castera、Maxime D. Crozet
    DOI:10.3987/com-05-10548
    日期:——
  • Rapid Synthesis of New Azaheterocyclic Hydroxymalonate Derivatives Using TDAE Approach
    作者:Patrice Vanelle、Marc Montana、Maxime D. Crozet、Caroline Castera-Ducros、Thierry Terme、Patrice Vanelle
    DOI:10.3987/com-07-11264
    日期:——
  • Targeting the human parasite Leishmania donovani: Discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series
    作者:Caroline Castera-Ducros、Lucie Paloque、Pierre Verhaeghe、Magali Casanova、Christophe Cantelli、Sébastien Hutter、Floriane Tanguy、Michèle Laget、Vincent Remusat、Anita Cohen、Maxime D. Crozet、Pascal Rathelot、Nadine Azas、Patrice Vanelle
    DOI:10.1016/j.bmc.2013.09.002
    日期:2013.11
    We report herein the discovery of antileishmanial molecules based on the imidazo[1,2-a]pyridine ring. In vitro screenings of imidazopyridines belonging to our chemical library, toward the promastigotes stage of Leishmania donovani, J774A. 1 murine and HepG2 human cells, permitted to identify three selective hit-compounds (12, 20 and 28). New derivatives were then synthesized to allow structure-activity and -toxicity relationships analyses, enabling to characterize a lead-compound (44) displaying both a high potency (IC50 = 1.8 mu M) and a good selectivity index, in comparison with three antileishmanial reference drug-compounds (amphotericin B, miltefosine and pentamidine). Moreover, lead-compound 44 also exhibits good in vitro activity against the intracellular amastigote stage of L. donovani. Thus, the 6-halo-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridine scaffold appears as a new promising selective antileishmanial pharmacophore, especially when substituted at position 8 by a bromine atom. (C) 2013 Elsevier Ltd. All rights reserved.
  • Efficient Synthesis of New 8-Aryl Tricyclic Pyridinones
    作者:Patrice Vanelle、Caroline Castera-Ducros、Maxime Crozet
    DOI:10.1055/s-2006-942505
    日期:2006.8
    New tricyclic pyridinones were synthesized from 6-bromo-2-chloromethyl-3-nitroimidazo[1,2-a]pyridine in four steps involving a Suzuki-Miyaura cross-coupling reaction and a direct olefination with diethyl ketomalonate as key steps. Subsequent one-pot reduction-cyclization provided new ethyl 8-aryl-2-oxo-1,2-dihydrodipyrido[1,2-a;3′,2′-d]imidazole-3-carboxylates.
    以 6-溴-2-氯甲基-3-硝基咪唑并[1,2-a]吡啶为原料,通过四个步骤合成了新的三环吡啶酮,其中关键步骤包括铃木-宫浦交叉偶联反应和与酮丙二酸二乙酯的直接烯化反应。随后的一锅还原-环化反应提供了新的 8-芳基-2-氧代-1,2-二氢二吡啶并[1,2-a;3′,2′-d]咪唑-3-羧酸乙酯。
查看更多

同类化合物

阿法拉定A,TFA 钠(E)-2-氰基-3-[2,8-二(丙-2-基氧基)咪唑并[3,2-a]吡啶-3-基]丙-2-烯酸酯 诺白拉斯啶 苯酚,4-(5,6,7,8-四氢咪唑并[1,2-a]吡啶-8-基)- 米诺膦酸 米诺磷酸一水合物 硫酸利美戈潘 盐酸法屈唑半水合物 盐酸依格列汀 甲基咪唑并[1,5-A]吡啶-1-甲酸叔丁酯 甲基3-氨基咪唑并[1,2-a]吡啶-5-羧酸酯 甲基-(7-甲基咪唑并[1,2-A〕吡啶-2-基甲基)-胺 甲基-(5-甲基-咪唑并[1,2-A]吡啶-2-甲基)-胺 甲基 2-甲基咪唑并[1,2-a]吡啶-3-羧酸 环戊烷羧酸2-氨基-4-亚甲基-,(1R,2S)-(9CI) 环巴胺抑制剂1 泰妥拉唑 法倔唑盐酸盐 法倔唑 沃利替尼(对映异构体) 沃利替尼 氨基膦酸杂质14 巴马鲁唑 奥克塞米索 地扎胍宁甲磺酸盐 地扎胍宁 土大黄甙 咪唑磺隆 咪唑并吡啶-2-酮盐酸盐 咪唑并吡啶-2-酮 咪唑并二甲基吡啶 咪唑并[2,1-a]异喹啉-2(3H)-酮 咪唑并[1,5-a]吡啶-8-胺 咪唑并[1,5-a]吡啶-8-羧酸乙酯 咪唑并[1,5-a]吡啶-8-甲醛 咪唑并[1,5-a]吡啶-7-羧酸甲酯 咪唑并[1,5-a]吡啶-7-羧酸乙酯 咪唑并[1,5-a]吡啶-6-羧酸甲酯 咪唑并[1,5-a]吡啶-6-羧酸乙酯 咪唑并[1,5-a]吡啶-5-胺 咪唑并[1,5-a]吡啶-5-羧酸甲酯 咪唑并[1,5-a]吡啶-5-羧酸乙酯 咪唑并[1,5-a]吡啶-5-甲醛 咪唑并[1,5-a]吡啶-3-羧酸乙酯 咪唑并[1,5-a]吡啶-3-磺酰胺 咪唑并[1,5-a]吡啶-3-甲醛 咪唑并[1,5-a]吡啶-3(2H)-硫酮 咪唑并[1,5-a]吡啶-1-羧醛 咪唑并[1,5-a]吡啶-1-磺酰胺 咪唑并[1,5-a]吡啶-1-基-甲醇